[AACR] Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma

cfhesq Post time 2022-12-18 22:46:43 | Show all posts |Read mode
Reward10points

journal£ºClinical Cancer Research

Authors£ºRichard P. Tobin; Dasha T. Cogswell; Victoria M. Cates; Dana M. Davis; Jessica S.W. Borgers; Robert J. Van Gulick; Elizabeth Katsnelson; Kasey L. Couts; Kimberly R. Jordan; Dexiang Gao; Eduardo Davila; Theresa M. Medina; Karl D. Lewis; Rene Gonzalez; Ross W. McFarland; William A. Robinson; Martin D. McCarter

Published date£º--

DOI£º10.1158/1078-0432.ccr-22-2495

Article link£ºhttp://dx.doi.org/10.1158/1078-0432.ccr-22-2495

Article Source£ºAmerican Association for Cancer Research (AACR)¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply3 Show all posts
Roman.Cling Post time 2022-12-18 22:46:44 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Georgee Post time 2022-12-18 22:55:27 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

cfhesq Post time 2022-12-24 06:28:40 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    30

Latest Reply

Return to the list